IVF denied as duplicate or overlapping therapy by UnitedHealthcare?

UnitedHealthcare's specific coverage criteria for IVF are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why UnitedHealthcare Denied IVF as Duplicate Therapy — and How to Appeal

A duplicate-therapy denial from UnitedHealthcare (UHC) in the context of IVF typically means the plan's review determined that a substantially equivalent fertility service is already authorized, has recently been provided, or that viable embryos from a prior retrieval are available for transfer — making a new stimulation cycle redundant in the plan's view. This denial reason may also appear when a different type of fertility treatment was authorized in the same benefit period and UHC treats them as interchangeable.

## Why This Denial Is Appealable

IVF procedures are not always clinically interchangeable. A frozen-embryo transfer (FET) from a prior cycle and a new fresh stimulation cycle serve different clinical purposes depending on embryo quality, embryo availability, and the patient's current clinical status. If prior authorized cycles failed, produced no viable embryos, or if the clinical picture has changed materially since the last authorization, your reproductive endocrinologist can document why the current request is not duplicative. UHC's clinical review does not have access to the full clinical narrative — that is the gap your appeal fills.

## Federal Appeal Framework

Under ACA §2719 and ERISA §503:

• Internal appeal: Submit within the timeframe on your denial notice (commonly 180 days for ERISA plans). Include a prescriber letter that directly addresses why the current request is clinically distinct from any prior authorized service.
• External review: After UHC upholds the internal denial, you generally have four months to request independent external review. The reviewer is not affiliated with UHC.
• Expedited review: Available when waiting poses a material health risk — relevant when ovarian reserve or treatment window is time-sensitive.

## Concrete Appeal Steps

1. Request the denial letter and identify the specific prior authorization or service UHC treated as equivalent to the current request. 2. Obtain UHC's current IVF coverage policy and review the criteria governing repeat cycles and benefit-period limits. 3. Request a complete IVF claims and authorization history from UHC to verify accuracy. 4. Have your reproductive endocrinologist write a medical-necessity letter that explains the clinical distinction between the prior authorized service and the current request — for example, absence of viable stored embryos, prior cycle failure, or changed clinical status. 5. Submit the internal appeal with all supporting documents and request a peer-to-peer review between your physician and UHC's medical director.

## Documentation Checklist

• Denial letter identifying the prior service UHC treated as equivalent
• Claims and authorization history for all prior IVF services
• Cycle outcome records (fertilization reports, embryo disposition, transfer outcomes)
• Prescriber letter explaining clinical distinction and current medical necessity
• Diagnosis documentation and current clinical status

## Criteria-Mapping Strategy

Obtain UHC's written IVF medical policy. For each criterion that defines when a new cycle is covered versus duplicative, provide the corresponding chart fact. Specifically address embryo availability, prior cycle outcomes, and clinical indication for a new retrieval. Structured, criterion-by-criterion documentation is consistently more effective than narrative appeals with UHC's review process.